This HTML5 document contains 118 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1160/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53671515
rdf:type
wikibase:Item
schema:description
2014年學術文章 2014年の論文 2014年學術文章 scientific article published on 4 December 2014 vitenskapelig artikkel научни чланак מאמר מדעי wetenschappelijk artikel artigo científico 2014年学术文章 vedecký článok bài báo khoa học wissenschaftlicher Artikel ৪ ডিসেম্বর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 4 December 2014 2014年學術文章 artikulong pang-agham vitskapeleg artikkel مقالة علمية نشرت في 4 ديسمبر 2014 научная статья 2014年學術文章 2014年学术文章 article científic article scientific наукова стаття, опублікована в грудні 2014 2014 nî lūn-bûn articolo scientifico tudományos cikk teaduslik artikkel artigo científico 2014年学术文章 bilimsel makale научни чланак επιστημονικό άρθρο 2014年学术文章 2014 թվականի դեկտեմբերի 4-ին հրատարակված գիտական հոդված scientific article published on 4 December 2014 artikull shkencor artykuł naukowy научна статия vědecký článek article scientifique 2014년 논문 2014年學術文章 tieteellinen artikkeli articol științific videnskabelig artikel scienca artikolo 2014年学术文章 บทความทางวิทยาศาสตร์ artikel ilmiah artigo científico 2014年学术文章 vetenskaplig artikel artículu científicu artículo científico publicado en 2014 naučni članak სამეცნიერო სტატია мақолаи илмӣ
p:P577
wds:Q53671515-B101C714-14D7-45EE-B0EB-731FFA4C7FC8
wdt:P577
2014-12-04T00:00:00Z
p:P2093
wds:Q53671515-30B32E14-0AAB-4806-8FDA-446704CF7F5F wds:Q53671515-AC487BD2-07C3-4B9B-A89E-DC649366983B wds:Q53671515-F17436A0-06BE-41A6-93A0-85E46554B48F
wdt:P2093
Martina Brueckmann Jeff S Healey Stuart J Connolly
rdfs:label
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
skos:prefLabel
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
schema:name
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
p:P50
wds:Q53671515-81A58239-767E-420F-9F72-EC355F788F00 wds:Q53671515-8BD7E077-D685-43E6-8AEF-B0E711E1A0C8 wds:Q53671515-9A289B36-22CF-4DC8-876D-B4CAFE51C57B wds:Q53671515-394E1AAF-AF81-4A05-899D-7CE02E4F8885 wds:Q53671515-4389286C-66AC-42EA-8C64-26231412EDB9 wds:Q53671515-454B0D17-2B9A-4A35-8ADF-CA95A001D467 wds:Q53671515-F2F113C1-8620-47C2-95CB-99B2DF36D08E wds:Q53671515-A7FA070D-6DD0-4571-8EE6-14E038FE5794 wds:Q53671515-E778D296-D924-48A0-8041-EAE4CF402D9B
wdt:P50
wd:Q44003025 wd:Q106086753 wd:Q110902282 wd:Q90710748 wd:Q42846212 wd:Q114775432 wd:Q100404477 wd:Q6230815 wd:Q51505621
p:P1476
wds:Q53671515-6395A0B6-EB05-4E5A-A26E-FB07A70E8B15
wdt:P1476
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
p:P304
wds:Q53671515-C0137B20-46ED-4D04-B1FF-2E7B698B4483
wdt:P304
625-632
p:P31
wds:Q53671515-92FB2A3F-200F-4503-B03D-90DC0FEEF511
wdt:P31
wd:Q13442814
p:P921
wds:Q53671515-FF7AB9AB-BF90-4A15-A1A4-2AD0FA824DB5 wds:Q53671515-E482A53F-377D-4550-BDF7-1103EC318D1E wds:Q53671515-7AA059BA-91BF-464A-A1AF-76C59A65DC7F wds:Q53671515-5D075514-BCE2-463C-A9CD-72266C72D941
wdt:P921
wd:Q419345 wd:Q407431 wd:Q63279445 wd:Q181600
p:P698
wds:Q53671515-935E08A2-51AB-4848-BAD3-43F1EF4F435A
wdtn:P698
n12:25472710
wdt:P698
25472710
p:P1433
wds:Q53671515-4C7C94E7-07DA-43B7-8FCD-E79FA8FC1CA7
wdt:P1433
wd:Q15724413
p:P433
wds:Q53671515-BA558143-E40D-4C61-8F0D-B7CDECC880F3
p:P478
wds:Q53671515-9789FF02-10C2-41EC-AD95-717D50ACD588
wdt:P433
3
wdt:P478
113
p:P356
wds:Q53671515-C163276F-9F67-4A62-8FDD-A488A3288CE8
wdtn:P356
n10:TH14-04-0305
wdt:P356
10.1160/TH14-04-0305